ACT Laboratories
Raising the Bar of Cannabis Medicine

Bob Miller, COO

Being at the intersection of Cannabis growers and processors, ACT Laboratories recognizes challenges faced by both the parties and strives to address them through science and technology. The lack of access to crucial data across the drug development lifecycle, from drug discovery to regulatory approval, has stifled innovation in the Cannabis medicine domain. “We solve the industry problems by bringing reliable and accurate data for safe and effective Cannabis medicine,” says Bob Miller, the COO of the company.

“The earlier we get involved in their current process, the more consultative we can be,” affirms Morse. During the initial interaction, team ACT Laboratories understands client’s business needs, maturity level of their operations, and works closely with their leadership to develop an effective strategy to tackle the problems.

ACT Laboratories takes an analytical approach in its testing strategy, focusing on a diverse range of areas and assays. The company’s dedicated QA department maintains an oversight of the operations for accurate assessment of the product under test.

On the operations side, ACT Laboratories’ technicians focus on isolating issues, whether it is a microbiological issue or other, to ensure high plant quality. “With such an all-encompassing engagement strategy, we act as the brain and hands of our clients, putting together the missing pieces of the puzzle to cater to the unique client requirements,” adds Miller.

Currently operating in four states with a fifth state coming on board within a month and two more states planned for later this year ACT Laboratories deeply understands the state regulations and works closely with the regulators to make it easy for its clients to stay one step ahead of the regulatory challenges. Its regulatory compliance function tracks changes in the regulations, enabling clients to respond to those changes in a timely fashion. Interestingly, ACT Laboratories supports both the participants, keeping its clients up-to-date with regulatory information while working with the regulators to provide multi-state perspectives to tailor the regulations in a way that enhances product safety.

In a case study, a Cannabis processor had submitted to ACT Laboratories their flower samples, which had been showing microbe failure periodically. Based on the results generated, ACT Laboratories had its microbiology and cultivation experts visit the client’s site and recommend changes in the handling of their produce and storage, which ultimately rectified the situation.

ACT Laboratories will focus on automation and gene therapy in the future. The company also stresses introducing PCR testing methods across its network to rectify shortcomings with traditional microbiology methods. Constantly aiming to expand its regional presence, ACT Laboratories takes the best practices in one state to other states, and this knowledge has emerged as the holy grail for companies operating in the industry.